Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 13, 2016 - Issue 7
Submit an article Journal homepage
362
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study

Alessandra LugaresiDepartment of Neuroscience, Imaging and Clinical Sciences, G. ‘d’Annunzio University’ - S.S. Annunziata Hospital, Chieti, ItalyCorrespondence[email protected]
,
Francesca De RobertisDepartment of Neurology, AUSL ‘Vito Fazzi’, Lecce, Italy
,
Marinella ClericoDivision of Neurology, Department of Clinical and Biological Science, S. ‘Luigi Gonzaga’ Hospital, University of Turin, Orbassano, Italy
,
Vincenzo Brescia MorraDepartment of Neurological Science, ‘Federico II’ University, Naples, Italy
,
Diego CentonzeDepartment of Neuroscience, Tor Vergata University, Rome & IRCCS Neuromed, Pozzilli, IS, Italy
,
Stefano BorghesanMedical Affairs Department Merck Serono, Rome, Italy
,
Giorgia Teresa ManiscalcoNeurology Clinic, Antonio Cardarelli Hospital, Naples, Italy
& on behalf of the RIVER study group show all
Pages 931-935 | Received 10 May 2015, Accepted 26 Jan 2016, Published online: 24 Feb 2016

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Yu-Ting Lin, Tamara Will, Charlotte Wickham, Petra Boeree, Dominic Jack & Matthew Keiser. (2023) Evolution of the RebiSmart® Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis. Patient Preference and Adherence 17, pages 1923-1933.
Read now
Francesco Piras, Lilian Arnaud, Eric Henninger, Matthew Keiser, Andrea Seitzinger, Dominic Jack & Quentin Le Masne. (2023) Assessment of adherence to, and persistence with, an electromechanical autoinjector for subcutaneous interferon beta-1a injections for multiple sclerosis treatment over 3 years. Expert Opinion on Drug Delivery 20:6, pages 863-870.
Read now
Beate Bittner, Chantal Schmit Chiesi, Saifuddin Kharawala, Gavneet Kaur & Johannes Schmidt. (2019) Connected drug delivery devices to complement drug treatments: potential to facilitate disease management in home setting. Medical Devices: Evidence and Research 12, pages 101-127.
Read now
Sibyl Wray, Brooke Hayward, Fernando Dangond & Barry Singer. (2018) Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study. Expert Opinion on Drug Delivery 15:2, pages 127-135.
Read now
Marieke Krol, Gert de Voer & Ulrike Osowski. (2017) Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart® injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis. Patient Preference and Adherence 11, pages 1189-1196.
Read now

Articles from other publishers (8)

Ryan Farej, Mark Rametta, Anneliese La Rose, Apryl Quillen & Kim McLeod. (2022) A Prospective, Observational, Multicenter Study Assessing Adherence to Interferon Beta-1b Therapy and Patient Satisfaction Using the BETACONNECT Auto-Injector. Neurology and Therapy 11:1, pages 373-384.
Crossref
Zbyšek Pavelek, Simona Halúsková, Jana Šarláková & Martin Vališ. (2020) Multiple sclerosis: adherence to treatment. Neurologie pro praxi 21:5, pages 380-383.
Crossref
L.A. Visser, C. Louapre, C.A. Uyl-de Groot & W.K. Redekop. (2020) Patient needs and preferences in relapsing-remitting multiple sclerosis: A systematic review. Multiple Sclerosis and Related Disorders 39, pages 101929.
Crossref
Francesco Saccà, Roberta Lanzillo, Alessio Signori, Giorgia T Maniscalco, Elisabetta Signoriello, Salvatore Lo Fermo, Annamaria Repice, Pietro Annovazzi, Damiano Baroncini, Marinella Clerico, Eleonora Binello, Raffaella Cerqua, Giorgia Mataluni, Simona Bonavita, Luigi Lavorgna, Ignazio Roberto Zarbo, Alice Laroni, Silvia Rossi, Lorena Pareja Gutierrez, Sara La Gioia, Barbara Frigeni, Valeria Barcella, Jessica Frau, Eleonora Cocco, Giuseppe Fenu, Valentina Torri Clerici, Arianna Sartori, Sarah Rasia, Cinzia Cordioli, Alessia Di Sapio, Simona Pontecorvo, Roberta Grasso, Caterina Barrilà, Cinzia Valeria Russo, Sabrina Esposito, Domenico Ippolito, Francesca Bovis, Fabio Gallo & Maria Pia Sormani. (2018) Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study. Multiple Sclerosis Journal 25:9, pages 1263-1272.
Crossref
Peter Rieckmann, Matthias Schwab, Dieter Pöhlau, Iris-Katharina Penner, Torsten Wagner, Elke Schel & Antonios Bayas. (2018) Adherence to Subcutaneous IFN β-1a in Multiple Sclerosis: Final Analysis of the Non-Interventional Study READOUTsmart Using the Dosing Log and Readout Function of RebiSmart®. Advances in Therapy 36:1, pages 175-186.
Crossref
Volker Limmroth, Iason Bartzokis, Eckhard Bonmann, Patrick Kusel, Thomas Schreiner & Markus Schürks. (2018) The BETACONNECT™ system: MS therapy goes digital. Neurodegenerative Disease Management 8:6, pages 399-410.
Crossref
Ingo Kleiter, Michael Lang, Judith Jeske, Christiane Norenberg, Barbara Stollfuß & Markus Schürks. (2017) Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study. BMC Neurology 17:1.
Crossref
Chiara Zecca, Giulio Disanto, Sarah Mühl & Claudio Gobbi. (2017) Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study. BMC Neurology 17:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.